Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01832363 · ClinicalTrials.gov registry record · Phase 2
Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI
A Phase 2 study of Asthma, sponsored by Xemed.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01832363: Completed Phase 2 study of Asthma, sponsored by Xemed.
NCT01832363 is a Phase 2 study of Asthma that has completed, run by Xemed. The registered enrollment target is 30 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01832363, a Phase 2 study of Asthma, has completed, sponsored by Xemed.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the bronchial thermoplasty treatment can be guided through hyperpolarized xenon lung MRI.
Primary Outcome
Asthma Quality of Life Questionnaire (AQLQ) is the primary outcome of this study. We will test whether the standard (unguided) three session BT treatment is superior to the a HXe MRI guided, single session BT treatment. There will be three time points of measure of the AQLQ score: before the BT session (baseline), 12 weeks after the first BT session, and 12 weeks after the third (last) BT session (approximately 36 weeks from baseline).
Conditions Studied
Interventions
- DRUG HXe MRI guided treatment sequence for BT
- OTHER Standard treatment sequence for BT (control)
Study Locations (1)
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-03 |
| Est. Completion | 2019-05 |
| Phase | Phase 2 |
What the finished NCT01832363 record still lists
NCT01832363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which HXe MRI guided treatment sequence for BT is the first listed.
NCT01832363 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT01832363 about?
NCT01832363 is a clinical study titled "Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI". The purpose of this study is to determine if the bronchial thermoplasty treatment can be guided through hyperpolarized xenon lung MRI.
What is the current status of trial NCT01832363?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2013-03. Estimated completion is 2019-05.
What conditions does trial NCT01832363 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01832363?
The interventions under investigation include: HXe MRI guided treatment sequence for BT (DRUG), Standard treatment sequence for BT (control) (OTHER).
Who is sponsoring clinical trial NCT01832363?
This trial is sponsored by Xemed, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01832363 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01832363's enrollment target sits among peer trials
30 305th of 374 higher than 66 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia